K. Steven LaForge - Concepedia

Author

K. Steven LaForge

Also Known As

K S LaForge, K Steven LaForge, K. S. LaForge, K. STEVEN LAFORGE, K. Steven LaFORGE, K. Steven LaForge, K. Steven Laforge, K.S. LaForge, K.Steven LaForge, K.Steven Laforge

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Rockefeller University National Institutes of Health Baylor College of Medicine Enzo Biochem (United States)State University of New York

About

K. Steven LaForge is an author at Rockefeller University specializing in medicine, genetics, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.2K
2	Natural Sciences	6	6	205
3	Health Sciences	3	3	123
4	Engineering	2	2	34
5	Public Health	1	1	222

K. Steven LaForge

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction Cherie E. Bond, K. Steven LaForge, Mingting Tian, Proceedings of the National Academy of Sciences	1998	1.1K
On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Anuradha Ray, K. Steven LaForge, Pravinkumar B. Sehgal Molecular and Cellular Biology Inr MotifMolecular RegulationImmunologyMre IiImmunologic Mechanism	1990	276
Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden Gavin Bart, Mary Jeanne Kreek, Jürg Ott, Neuropsychopharmacology Opioid EpidemicSubstance UseGenetic EpidemiologySubstance Use DisordersAttributable Risk	2004	222
The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor Thomas Kroslak, K. Steven LaForge, Robert Gianotti, Journal of Neurochemistry	2007	214
Differential gene expression in the rat caudate putamen after “binge” cocaine administration: Advantage of triplicate microarray analysis Vadim Yuferov, Thomas Kroslak, K. Steven LaForge, Synapse	2003	142
Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. Yan Zhou, Rudolph Spangler, K. Steven LaForge, Journal of Pharmacology and Experimental Therapeutics	1996	137
Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells Jean Peluso, K. Steven LaForge, Hans W. D. Matthes, Journal of Neuroimmunology InflammationImmune CellsPain MedicineMedicineImmunology	1998	132
Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction Vadim Yuferov, D. P. Fussell, K. Steven LaForge, Pharmacogenetics	2004	126
A high-density association screen of 155 ion transport genes for involvement with common migraine Dale R. Nyholt, K. Steven LaForge, Mikko Kallela, Human Molecular Genetics	2008	106
Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse Andrew C. H. Chen, K. Steven LaForge, Ann Ho, American Journal of Medical Genetics	2002	80

Page 1